Clinical problem-solving. High time for action. Kallianpur AR, Poehling KA, Dittus RS (2001) N Engl J Med 344: 48-51 Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis. Tucker EI, Verbout NG, Leung PY, Hurst S, McCarty OJ, Gailani D, Gruber A (2012) Blood 119: 4762-8 Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation. Massion PB, Peters P, Ledoux D, Zimermann V, Canivet JL, Massion PP, Damas P, Gothot A (2012) Intensive Care Med 38: 1326-35 Associations of markers of inflammation and coagulation with delirium during critical illness. Girard TD, Ware LB, Bernard GR, Pandharipande PP, Thompson JL, Shintani AK, Jackson JC, Dittus RS, Ely EW (2012) Intensive Care Med 38: 1965-73 On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Barnes P, Cox JL, Lappas DG (1994) Anesthesiology 80: 338-51 Monitoring activity of fibrinolytic agents. A therapeutic challenge. Shafer KE, Santoro SA, Sobel BE, Jaffe AS (1984) Am J Med 76: 879-86 Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation. Olson JD, Brockway WJ, Fass DN, Magnuson MA, Bowie EJ (1975) Am J Clin Pathol 63: 210-8 Coagulopathies in orthopaedics: links to inflammation and the potential of individualizing treatment strategies. Stutz CM, O'Rear LD, O'Neill KR, Tamborski ME, Crosby CG, Devin CJ, Schoenecker JG (2013) J Orthop Trauma 27: 236-41
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.